Hikma Pharmaceuticals
High-quality accessible medicines
- B2B
About Hikma Pharmaceuticals
Manufacturing and supplying over 800 generic, specialty, and branded pharmaceutical products to hospitals, physicians, and pharmacists globally.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- London, United Kingdom
- Founded
- 1978
- Revenue
- $3.3BFY2025, publicly reported
- Website
- hikma.com
Hikma Pharmaceuticals in the news
- Hikma stock heads into the open after a modest gain
Hikma's stock rose 0.7% on September 15, 2026, closing at GBP 19.18 on the London Stock Exchange, outperforming the FTSE 100.
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
Hikma Pharmaceuticals will pay an interim dividend on September 17, 2026, declared in US dollars, reflecting its strong US market presence in generics and injectables.
- Hikma Pharmaceuticals climbs Friday, outperforms market
Hikma Pharmaceuticals PLC shares gained 2.20% on Friday, outperforming the broader market.
- A needle-free epinephrine spray is under review in the US, Europe and UK
Hikma Pharmaceuticals' investigational needle-free epinephrine nasal spray for anaphylaxis is currently undergoing regulatory review in the US, Europe, and the UK, with additional filings in Canada and planned global submissions.
- Hikma advances its epinephrine nasal spray with multi-market regulatory filings
Hikma Pharmaceuticals' epinephrine nasal spray for anaphylaxis is undergoing regulatory review in multiple markets including the US, Europe, and the UK.
Hikma Pharmaceuticals at a glance
Hikma Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in London, United Kingdom.
Hikma Pharmaceuticals was founded in 1978.
Hikma Pharmaceuticals has 10,000+ employees.
Hikma Pharmaceuticals's revenue is $3.3B (FY2025, publicly reported).
Selling to companies like Hikma Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies